NVDA Q2 Guide of $91B Excludes China, Testing the AI Capex Bull Case
Nvidia's $91B Q2 revenue guidance assumes zero mainland China contribution, making it a clean baseline for hyperscaler demand across MSFT, GOOGL, META, and AMZN. At 33x forward earnings on 80%+ revenue growth, the market is pricing perfection, lifting Nasdaq breadth but sharpening valuation risk for ^IXIC concentration
RKey facts
- Nvidia Q1 revenue $81.6B, data-center revenue $75.2B, both records
- Q2 guidanceCompany-issued forecasts of future financial performance.: $91B revenue, excluding any China mainland contribution
- GAAP net income $58.3B; forward P/E at 33x despite 80%+ revenue growth
- Management confirmed all major hyperscalers (MSFT, GOOGL, META, AMZN) raising capex
What's happening
Nvidia's earnings report late Thursday fundamentally shifted the conversation around AI capex sustainability. The company posted $81.6B in Q1 revenue, a record, with $75.2B from data-center alone. The forward guide to $91B for the coming quarter was the headline that mattered most: it excluded any contribution from China operations, meaning management delivered a number that already assumes zero mainland revenue. This is critical context in a debate where bears have spent weeks arguing that hyperscaler spending would inevitably cool or that China restrictions would bite harder than expected.
The $91B guide amounts to roughly 13% sequential growth in an already-massive quarter. Jensen Huang held no giveaways in the call; he underscored that demand remains broad-based across all major cloud providers. Goldman, Morgan Stanley, and other sell-side houses had just spent weeks fielding questions on whether the AI trade had peaked. Nvidia's numbers are the most credible rebuttal available: MSFT, GOOGL, META, and AMZN all raised capex guidanceCompany-issued forecasts of future financial performance. in recent weeks, and Nvidia's results validate that those commitments are real and flowing through to orders.
Cross-asset implications are material. Semiconductor peers AMD and AVGO rallied hard on the data, and the Nasdaq breadth expanded, easing some concentration-risk anxiety for SPY holders. Memory-chip makers and infrastructure plays benefit from sustained capex cycles. The only concern is valuation: NVDA trades at roughly 33x forward earnings despite 80%+ revenue growth. Market is pricing in perfection, but at least now that perfection has a credible near-term roadmap.
Skeptics point to one risk: the $91B guide is still sequential growth, not explosive acceleration. If that rate of growth slows in the following quarter, it could spook investors who have come to expect perpetual acceleration. Additionally, China exposure remains a wild card; if US export restrictions tighten further, management may have to revise guidanceCompany-issued forecasts of future financial performance. downward.
What to watch next
- PR Newswire FinancialEightco Holdings (NASDAQ: ORBS) meldet Gesamtbestände von etwa 337 Mio. USD, darunter OpenAI, Beast Industries, mehr als 11.000 ETH und über 283 Millionen WLD-Token
Zusammensetzung der Treasury-Bestände von Eightco zum 20. Mai 2026: 90 Mio. USD OpenAI-Aktien (indirekt), 18 Mio. USD Beast Industries-Aktien, 11.068 ETH, 283 Mio. WLD-Bestände und 133 Mio. USD Zahlungsmittel und Zahlungsmitteläquivalente, insgesamt etwa 337 Mio. USD World bietet eine...
21m ago - CointelegraphCrypto Biz: Institutions tighten their grip on Bitcoin, AI and prediction markets
Institutional crypto adoption accelerates as Tether expands Bitcoin holdings, miners pivot to AI and Polymarket joins Nasdaq amid $1 billion fund outflows.
44m ago - PR Newswire FinancialMedpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, May 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU SUFFERED A LOSS ON YOUR...
46m ago - PR Newswire FinancialAtara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, May 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ: ATRA). IF YOU SUFFERED A LOSS ON YOUR...
46m ago - Nikkei AsiaKawasaki Heavy to partner with Nvidia on physical AI, open US robot center1h ago
- Nikkei AsiaKOSPI jumps 8.4% on Samsung strike suspension, Nvidia results1h ago
- Nikkei AsiaEditor's Choice: Nvidia and Asia's three chip giants cash in on AI gold rush1h ago
- Yahoo FinanceCerebras Systems' Chips May Be 15X Faster Than Some of Nvidia's Blackwell Models, but Nvidia Has 2 Distinct Advantages1h ago
Related coverage
- NVDA Q2 Guide of $91B Excludes China, While Hyperscalers Raise CapexTech & AI··0 mentions
- NVDA Q2 Guidance Hits $91B With Zero China Revenue Priced InTech & AI··0 mentions
- NVDA Q2 Guidance of $91B Excludes China, Hyperscaler Capex Still FlowingTech & AI··0 mentions
- NVDA Guides $91B Q2 2026 With Zero China Revenue IncludedTech & AI··0 mentions
More about $NVDA
- ARM Reprices to 100x Forward P/E on Vera Royalties Analysts Cap at $400M-$1B·Tech & AI
- ARM Rallies 15% to $256.59 on Vera Royalties Worth at Most $150M Annually·Tech & AI
- SpaceX IPO at Up to $250B Could Push S&P 500 Tech Weight to 45%·Equities US
- META $145B Capex Plan Paired With 8,000 Layoffs Validates Hyperscaler AI Consensus·Tech & AI
- NVDA $91B Q2 Guidance Holds Despite China Exclusion, but 40% S&P Concentration Deepens·Tech & AI
Tracking AI infrastructure capex — hyperscaler spend, data center buildouts, memory demand and the margin compression risk.